Logo image of QDEL

QUIDELORTHO CORP (QDEL) Stock Price, Quote, News and Overview

NASDAQ:QDEL - Nasdaq - US2197981051 - Common Stock - Currency: USD

28.09  +0.31 (+1.12%)

After market: 28.09 0 (0%)

QDEL Quote, Performance and Key Statistics

QUIDELORTHO CORP

NASDAQ:QDEL (4/25/2025, 8:00:01 PM)

After market: 28.09 0 (0%)

28.09

+0.31 (+1.12%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High49.45
52 Week Low23.77
Market Cap1.89B
Shares67.45M
Float66.93M
Yearly DividendN/A
Dividend YieldN/A
PE15.18
Fwd PE11.69
Earnings (Next)05-07 2025-05-07/amc
IPO02-01 1991-02-01


QDEL short term performance overview.The bars show the price performance of QDEL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 -20 -30

QDEL long term performance overview.The bars show the price performance of QDEL in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of QDEL is 28.09 USD. In the past month the price decreased by -21.69%. In the past year, price decreased by -29.14%.

QUIDELORTHO CORP / QDEL Daily stock chart

QDEL Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 26.96 223.47B
ISRG INTUITIVE SURGICAL INC 67.35 184.36B
BSX BOSTON SCIENTIFIC CORP 37.74 150.72B
SYK STRYKER CORP 29.95 139.34B
MDT MEDTRONIC PLC 15.76 107.94B
BDX BECTON DICKINSON AND CO 14.74 58.89B
EW EDWARDS LIFESCIENCES CORP 29.25 44.70B
IDXX IDEXX LABORATORIES INC 38.88 35.45B
RMD RESMED INC 25.98 34.64B
GEHC GE HEALTHCARE TECHNOLOGY 15.24 31.33B
DXCM DEXCOM INC 43.43 28.10B
PHG KONINKLIJKE PHILIPS NVR- NY 15.94 23.53B

About QDEL

Company Profile

QDEL logo image QuidelOrtho Corp. operates as a vitro diagnostics company. The company is headquartered in San Diego, California and currently employs 6,600 full-time employees. The firm specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. The company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.

Company Info

QUIDELORTHO CORP

9975 Summers Ridge Road

San Diego CALIFORNIA 92121 US

CEO: Douglas C. Bryant

Employees: 7100

Company Website: https://www.quidelortho.com/

Investor Relations: https://ir.quidel.com/

Phone: 18585521100

QUIDELORTHO CORP / QDEL FAQ

What is the stock price of QUIDELORTHO CORP today?

The current stock price of QDEL is 28.09 USD. The price increased by 1.12% in the last trading session.


What is the ticker symbol for QUIDELORTHO CORP stock?

The exchange symbol of QUIDELORTHO CORP is QDEL and it is listed on the Nasdaq exchange.


On which exchange is QDEL stock listed?

QDEL stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for QUIDELORTHO CORP stock?

15 analysts have analysed QDEL and the average price target is 54.35 USD. This implies a price increase of 93.49% is expected in the next year compared to the current price of 28.09. Check the QUIDELORTHO CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is QUIDELORTHO CORP worth?

QUIDELORTHO CORP (QDEL) has a market capitalization of 1.89B USD. This makes QDEL a Small Cap stock.


How many employees does QUIDELORTHO CORP have?

QUIDELORTHO CORP (QDEL) currently has 7100 employees.


What are the support and resistance levels for QUIDELORTHO CORP (QDEL) stock?

QUIDELORTHO CORP (QDEL) has a resistance level at 28.1. Check the full technical report for a detailed analysis of QDEL support and resistance levels.


Is QUIDELORTHO CORP (QDEL) expected to grow?

The Revenue of QUIDELORTHO CORP (QDEL) is expected to decline by -2.54% in the next year. Check the estimates tab for more information on the QDEL EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy QUIDELORTHO CORP (QDEL) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does QUIDELORTHO CORP (QDEL) stock pay dividends?

QDEL does not pay a dividend.


When does QUIDELORTHO CORP (QDEL) report earnings?

QUIDELORTHO CORP (QDEL) will report earnings on 2025-05-07, after the market close.


What is the Price/Earnings (PE) ratio of QUIDELORTHO CORP (QDEL)?

The PE ratio for QUIDELORTHO CORP (QDEL) is 15.18. This is based on the reported non-GAAP earnings per share of 1.85 and the current share price of 28.09 USD. Check the full fundamental report for a full analysis of the valuation metrics for QDEL.


What is the Short Interest ratio of QUIDELORTHO CORP (QDEL) stock?

The outstanding short interest for QUIDELORTHO CORP (QDEL) is 6.06% of its float. Check the ownership tab for more information on the QDEL short interest.


QDEL Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

QDEL Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to QDEL. Both the profitability and financial health of QDEL have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

QDEL Financial Highlights

Over the last trailing twelve months QDEL reported a non-GAAP Earnings per Share(EPS) of 1.85. The EPS decreased by -55.21% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -31.94%
ROE -68.76%
Debt/Equity 0.72
Chartmill High Growth Momentum
EPS Q2Q%-46.15%
Sales Q2Q%-4.69%
EPS 1Y (TTM)-55.21%
Revenue 1Y (TTM)-7.17%

QDEL Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 76% to QDEL. The Buy consensus is the average rating of analysts ratings from 15 analysts.

For the next year, analysts expect an EPS growth of 29.93% and a revenue growth -2.54% for QDEL


Ownership
Inst Owners109.74%
Ins Owners0.49%
Short Float %6.06%
Short Ratio3.57
Analysts
Analysts76
Price Target54.35 (93.49%)
EPS Next Y29.93%
Revenue Next Year-2.54%